Tufts Center for the Study of Drug Development
| Formation | 1976 |
|---|---|
| Founder | Louis Lasagna |
| Type | Think tank |
| Purpose | Researching drug development |
| Location | |
|
Director
|
Kenneth I. Kaitin |
| Website | csdd |
The Tufts Center for the Study of Drug Development is a nonprofit think tank at Tufts University in Boston, dedicated to researching drug development. It was established in 1976 by American physician Louis Lasagna.[1] The Center receives 40% of its funding from the pharmaceutical industry.[2]
Research
The Center has issued numerous studies estimating the cost of developing a new drug: In 2001, researchers from the Center estimated that the cost of doing so was $802 million,[3] and in 2014, they released a study estimating that this amount had risen to nearly $2.6 billion.[2] This study was criticized by Medecins Sans Frontieres, which said it was unreliable because the industry's research and development spending is not made public.[4] Aaron Carroll of the New York Times also criticized the study, saying it "contains a lot of assumptions that tend to favor the pharmaceutical industry."[5]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." /><templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about a United States health organization is a stub. You can help Wikipedia by expanding it. |
